Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer

被引：0
|
作者：
Dasharath Chaudhari
Kaushik Kuche
Vivek Yadav
Rohan Ghadi
Tushar Date
Nallamothu Bhargavi
Sanyog Jain
机构：
[1] National Institute of Pharmaceutical Education and Research (NIPER),Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics
来源：
Drug Delivery and Translational Research | 2023年 / 13卷
关键词：
Adenosine; Paclitaxel; Triple-negative breast cancer; PLGA nanoparticles; Adenosine receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1074 / 1087
页数：13
相关论文
共 50 条
  • [41] Auranofin-Loaded Chitosan Nanoparticles Demonstrate Potency against Triple-Negative Breast Cancer
    Afrifa, Maame Abena O.
    Kim, Jong H.
    Pitton, Kathryn A.
    Olelewe, Chibuzor
    Arojojoye, Adedamola S.
    Strachan, Douglas R.
    Suckow, Mark A.
    Awuah, Samuel G.
    ACS APPLIED BIO MATERIALS, 2024, 7 (03) : 2012 - 2022
  • [42] Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysis
    Gao, Wei
    Sun, Linlin
    Gai, Jinwei
    Cao, Yinan
    Zhang, Shuqun
    Xu, Yunzhao
    PLOS ONE, 2024, 19 (01):
  • [43] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
    Schmid, P.
    Adams, S.
    Rugo, H. S.
    Schneeweiss, A.
    Barrios, C. H.
    Iwata, H.
    Dieras, V.
    Hegg, R.
    Im, S. -A.
    Wright, G. Shaw
    Henschel, V.
    Molinero, L.
    Chui, S. Y.
    Funke, R.
    Husain, A.
    Winer, E. P.
    Loi, S.
    Emens, L. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2108 - 2121
  • [44] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
    Altundag, Kadri
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10): : 986 - 987
  • [45] Analysis of Paclitaxel-induced apoptosis in triple-negative breast cancer
    Nakajima, Wataru
    Kurita, Tomoko
    Naito, Zenya
    Takei, Hiroyuki
    Tanaka, Nobuyuki
    CANCER SCIENCE, 2018, 109 : 461 - 461
  • [46] Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells
    Sezer, Gulay
    Caner, Armagan
    Onal, Muge Gulcihan
    Cumaoglu, Ahmet
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 156 (01) : 70 - 76
  • [47] Targeting DNA methylation for treating triple-negative breast cancer
    Yu, Jia
    Zayas, Jacqueline
    Qin, Bo
    Wang, Liewei
    PHARMACOGENOMICS, 2019, 20 (16) : 1151 - 1157
  • [48] Targeting triple-negative breast cancer: optimising therapeutic outcomes
    Gelmon, K.
    Dent, R.
    Mackey, J. R.
    Laing, K.
    McLeod, D.
    Verma, S.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2223 - 2234
  • [49] BCL11A—targeting triple-negative breast cancer?
    Alessia Errico
    Nature Reviews Clinical Oncology, 2015, 12 (3) : 127 - 127
  • [50] Targeting nuclear receptors and their coregulators in triple-negative breast cancer
    Chang, Ya-Fang
    Wang, Yuhao
    Greene, Geoffrey
    CANCER RESEARCH, 2016, 76
12345